Deucravacitinib Long-Term Efficacy in Week 16 Placebo Crossovers: 3-year Results from the POETYK PSO Program. (2024). SKIN The Journal of Cutaneous Medicine, 8(2), s365. https://doi.org/10.25251/skin.8.supp.365